Financials (USD)
Sales 2024 * | 117M | Sales 2025 * | 130M | Capitalization | 74.1M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.57 x |
P/E ratio 2024 * |
-6.5
x | P/E ratio 2025 * |
156
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 19-01-31 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 19-06-30 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 03-10-31 |
James Tyree
BRD | Director/Board Member | 71 | 16-09-30 |
William McKee
BRD | Director/Board Member | 62 | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+28.79% | 676B | |
+24.74% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.23% | 210B | |
-0.21% | 204B | |
-9.69% | 194B | |
-11.71% | 144B |